Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Celltrion has announced its Corporate Value-up Program, targeting an average annual revenue growth of over 30% (’25–’27), an ROE of over 7% by 2027, and a 3-year average shareholder return ratio of 40%.
📊 [Key Disclosure Details & Financial Summary]
- Disclosure Title: Corporate Value-up Plan (Voluntary Disclosure)
- Plan Name: Celltrion Corporate Value-up Program
- Board Resolution & Posting Date: March 24, 2026
- Mid-to-Long Term Value-up Targets (’25–’27):
- Revenue Growth: Target average annual growth rate (CAGR) of 30%+ from 2025 to 2027
- Profitability Improvement: Target ROE (Return on Equity) of 7%+ by 2027
- Shareholder Return: Target 3-year average shareholder return ratio of 40% from 2025 to 2027
- Action Plans by Objective:
- Revenue Growth: Expanding commercial biosimilar portfolio, scaling CMO business, and broadening R&D areas
- Profitability: Improving cost-of-goods-sold (COGS) ratio and optimizing SG&A expenses
- Shareholder Return: Retiring 9.11 million treasury shares (approx. KRW 1.7T in value) and gradually increasing cash dividends targeting 30% of EBITDA-CAPEX
- Shareholder Communication: Reviewing 2025 achievements and establishing the 2026 communication roadmap
- High-Dividend Company Status (Tax Exemption Act): N/A (Not Applicable)
- Official Website: https://www.celltrion.com/ko-kr/investment/notice/announce
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Monitoring Progress on Mid-to-Long Term Targets and Periodic Reports
This voluntary disclosure outlines Celltrion’s corporate value-up program, making it important to track actual annual performance against the targets for revenue growth, ROE improvement, and 40% shareholder returns. Monitoring annual execution is essential to evaluate progress given that voluntary disclosures involve forward-looking estimates. Execution details regarding financial metrics, share cancellations, and cash dividend payouts can be verified in upcoming periodic filings (Quarterly, Half-Yearly, or Annual Business Reports) under ‘Management Discussion and Analysis’, ‘Total Number of Shares’, and ‘Matters Related to Dividends’, as well as official IR materials.
📢 Disclaimer & Source Information
Source: This content was newly generated and structured based on official data submitted to the Data Analysis, Retrieval and Transfer System (DART) of the Financial Supervisory Service.
Investment Risk Notice: This information is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.
Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.
